Extensive acute deep vein thrombosis of the iliocaval segment: midterm results of thrombolysis and stent placement

Standard

Extensive acute deep vein thrombosis of the iliocaval segment: midterm results of thrombolysis and stent placement. / Kölbel, Tilo; Lindh, Mats; Holst, Jan; Uher, Petr; Eriksson, Karl-Fredrik; Sonesson, Björn; Malina, Martin; Ivancev, Krasnodar.

In: J VASC INTERV RADIOL, Vol. 18, No. 2, 02.2007, p. 243-250.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{1cbd39ca216d4ca29d79a17fc263249a,
title = "Extensive acute deep vein thrombosis of the iliocaval segment: midterm results of thrombolysis and stent placement",
abstract = "PURPOSE: To evaluate patency and clinical outcome in patients treated with catheter-directed thrombolysis and stent placement for acute extensive thrombosis affecting the iliocaval segment.MATERIALS AND METHODS: During a 10-year period (1994-2005), 37 patients with 44 limbs (26 female, median age 31 years) with acute extensive venous thrombosis affecting the iliocaval segment were treated with catheter-directed thrombolysis. Angioplasty and stent placement was performed in 36 limbs (82%) for underlying stenosis or residual thrombosis. A prospectively registered database was analyzed in combination with a telephone interview about clinical symptoms.RESULTS: Technical success was achieved in all 44 limbs and clinical success in 42 of 44 (96%) limbs. Primary patency after a median imaging follow-up interval of 16 months was 34 of 44 (77%) limbs, assisted primary patency was 38 of 44 (86%) limbs, and secondary patency was 39 of 44 (89%) limbs. Thirty of 44 (68%) limbs were asymptomatic after a median clinical follow-up of 27 months, eight (18%) limbs were moderately improved, two (5%) limbs were unchanged, two (5%) limbs were moderately worse, and two (5%) limbs had no clinical follow-up. Complications occurred in six (16%) patients, three (8%) of which were major complications. No patient developed symptomatic pulmonary embolism.CONCLUSIONS: Catheter-directed thrombolysis and stent placement is a safe and effective treatment for acute iliocaval thrombosis. Clinical midterm results are encouraging. Thrombolyzed and stented segments remain patent in the vast majority of patients after 16 months. Primary and aggressive stent placement in the iliocaval vein segments can prevent rethrombosis and ensure patency.",
keywords = "Acute Disease, Adult, Angioplasty, Balloon, Anticoagulants/therapeutic use, Databases as Topic, Female, Follow-Up Studies, Heparin/therapeutic use, Humans, Iliac Vein, Leg/blood supply, Male, Prospective Studies, Radiography, Interventional, Stents, Stockings, Compression, Thrombolytic Therapy/methods, Treatment Outcome, Ultrasonography, Interventional, Vascular Patency, Vena Cava, Inferior, Venous Thrombosis/therapy, Warfarin/therapeutic use",
author = "Tilo K{\"o}lbel and Mats Lindh and Jan Holst and Petr Uher and Karl-Fredrik Eriksson and Bj{\"o}rn Sonesson and Martin Malina and Krasnodar Ivancev",
year = "2007",
month = feb,
doi = "10.1016/j.jvir.2006.12.002",
language = "English",
volume = "18",
pages = "243--250",
journal = "J VASC INTERV RADIOL",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Extensive acute deep vein thrombosis of the iliocaval segment: midterm results of thrombolysis and stent placement

AU - Kölbel, Tilo

AU - Lindh, Mats

AU - Holst, Jan

AU - Uher, Petr

AU - Eriksson, Karl-Fredrik

AU - Sonesson, Björn

AU - Malina, Martin

AU - Ivancev, Krasnodar

PY - 2007/2

Y1 - 2007/2

N2 - PURPOSE: To evaluate patency and clinical outcome in patients treated with catheter-directed thrombolysis and stent placement for acute extensive thrombosis affecting the iliocaval segment.MATERIALS AND METHODS: During a 10-year period (1994-2005), 37 patients with 44 limbs (26 female, median age 31 years) with acute extensive venous thrombosis affecting the iliocaval segment were treated with catheter-directed thrombolysis. Angioplasty and stent placement was performed in 36 limbs (82%) for underlying stenosis or residual thrombosis. A prospectively registered database was analyzed in combination with a telephone interview about clinical symptoms.RESULTS: Technical success was achieved in all 44 limbs and clinical success in 42 of 44 (96%) limbs. Primary patency after a median imaging follow-up interval of 16 months was 34 of 44 (77%) limbs, assisted primary patency was 38 of 44 (86%) limbs, and secondary patency was 39 of 44 (89%) limbs. Thirty of 44 (68%) limbs were asymptomatic after a median clinical follow-up of 27 months, eight (18%) limbs were moderately improved, two (5%) limbs were unchanged, two (5%) limbs were moderately worse, and two (5%) limbs had no clinical follow-up. Complications occurred in six (16%) patients, three (8%) of which were major complications. No patient developed symptomatic pulmonary embolism.CONCLUSIONS: Catheter-directed thrombolysis and stent placement is a safe and effective treatment for acute iliocaval thrombosis. Clinical midterm results are encouraging. Thrombolyzed and stented segments remain patent in the vast majority of patients after 16 months. Primary and aggressive stent placement in the iliocaval vein segments can prevent rethrombosis and ensure patency.

AB - PURPOSE: To evaluate patency and clinical outcome in patients treated with catheter-directed thrombolysis and stent placement for acute extensive thrombosis affecting the iliocaval segment.MATERIALS AND METHODS: During a 10-year period (1994-2005), 37 patients with 44 limbs (26 female, median age 31 years) with acute extensive venous thrombosis affecting the iliocaval segment were treated with catheter-directed thrombolysis. Angioplasty and stent placement was performed in 36 limbs (82%) for underlying stenosis or residual thrombosis. A prospectively registered database was analyzed in combination with a telephone interview about clinical symptoms.RESULTS: Technical success was achieved in all 44 limbs and clinical success in 42 of 44 (96%) limbs. Primary patency after a median imaging follow-up interval of 16 months was 34 of 44 (77%) limbs, assisted primary patency was 38 of 44 (86%) limbs, and secondary patency was 39 of 44 (89%) limbs. Thirty of 44 (68%) limbs were asymptomatic after a median clinical follow-up of 27 months, eight (18%) limbs were moderately improved, two (5%) limbs were unchanged, two (5%) limbs were moderately worse, and two (5%) limbs had no clinical follow-up. Complications occurred in six (16%) patients, three (8%) of which were major complications. No patient developed symptomatic pulmonary embolism.CONCLUSIONS: Catheter-directed thrombolysis and stent placement is a safe and effective treatment for acute iliocaval thrombosis. Clinical midterm results are encouraging. Thrombolyzed and stented segments remain patent in the vast majority of patients after 16 months. Primary and aggressive stent placement in the iliocaval vein segments can prevent rethrombosis and ensure patency.

KW - Acute Disease

KW - Adult

KW - Angioplasty, Balloon

KW - Anticoagulants/therapeutic use

KW - Databases as Topic

KW - Female

KW - Follow-Up Studies

KW - Heparin/therapeutic use

KW - Humans

KW - Iliac Vein

KW - Leg/blood supply

KW - Male

KW - Prospective Studies

KW - Radiography, Interventional

KW - Stents

KW - Stockings, Compression

KW - Thrombolytic Therapy/methods

KW - Treatment Outcome

KW - Ultrasonography, Interventional

KW - Vascular Patency

KW - Vena Cava, Inferior

KW - Venous Thrombosis/therapy

KW - Warfarin/therapeutic use

U2 - 10.1016/j.jvir.2006.12.002

DO - 10.1016/j.jvir.2006.12.002

M3 - SCORING: Journal article

C2 - 17327557

VL - 18

SP - 243

EP - 250

JO - J VASC INTERV RADIOL

JF - J VASC INTERV RADIOL

SN - 1051-0443

IS - 2

ER -